Viewing StudyNCT00063934



Ignite Creation Date: 2024-05-05 @ 11:30 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00063934
Status: TERMINATED
Last Update Posted: 2019-03-05
First Post: 2003-07-08

Brief Title: Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Organization Data

Organization: National Cancer Institute NCI
Class: NIH
Study ID: NCI-2012-02885
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: National Cancer Institute NCI
Lead Sponsor Class: NIH
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators